India Osteoarthritis Therapeutics Market Size & Outlook
The osteoarthritis therapeutics market in India is expected to reach a projected revenue of US$ 166.4 million by 2033. A compound annual growth rate of 9.8% is expected of India osteoarthritis therapeutics market from 2026 to 2033.
India osteoarthritis therapeutics market highlights
The India osteoarthritis therapeutics market generated a revenue of USD 77.5 million in 2025 and is expected to reach USD 166.4 million by 2033.
The India market is expected to grow at a CAGR of 9.8% from 2026 to 2033.
In terms of segment, viscosupplements was the largest revenue generating product in 2025.
Autologous Chondrocyte Implantation (ACI), Including MACI is the most lucrative product segment registering the fastest growth during the forecast period.
Osteoarthritis therapeutics market data book summary
Market revenue in 2025
USD 77.5 million
Market revenue in 2033
USD 166.4 million
Growth rate
9.8% (CAGR from 2026 to 2033)
Largest segment
Viscosupplements
Fastest growing segment
Autologous Chondrocyte Implantation (ACI), Including MACI
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Platelet-Rich Plasma (PRP) Therapy, Autologous Chondrocyte Implantation (ACI), Including MACI, Adipose Tissue Therapy, BMAC (Bone Marrow Aspirate Concentrate) Therapy, Stem Cell (other), Bone Graft Substitutes, Viscosupplements, Other (Cartilage Resurfacing Products)
Key market players worldwide
GlaxoSmithKline Consumer Healthcare (GSK CH India), Sanofi SA, Pfizer Inc, Bayer AG, Zimmer Biomet Holdings Inc, Novartis AG ADR, Anika Therapeutics Inc, Assertio Holdings Inc, Bioventus Inc Class A
Other key industry trends
In terms of revenue, India accounted for 1.4% of the global osteoarthritis therapeutics market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China osteoarthritis therapeutics market is projected to lead the regional market in terms of revenue in 2033.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 301.4 million by 2033.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Osteoarthritis Therapeutics Market Outlook will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 73.55% in 2025.
Horizon Databook has segmented the India osteoarthritis therapeutics market based on platelet-rich plasma (prp) therapy, autologous chondrocyte implantation (aci), including maci, adipose tissue therapy, bmac (bone marrow aspirate concentrate) therapy, stem cell (other), bone graft substitutes, viscosupplements, other (cartilage resurfacing products) covering the revenue growth of each sub-segment from 2021 to 2033.
India Osteoarthritis Therapeutics Market Product Outlook (Revenue, USD Million , 2021-2033)
Platelet-Rich Plasma (PRP) Therapy
Autologous Chondrocyte Implantation (ACI), Including MACI
Adipose Tissue Therapy
BMAC (Bone Marrow Aspirate Concentrate) Therapy
Stem Cell (other)
Bone Graft Substitutes
Viscosupplements
Other (Cartilage Resurfacing Products)
India Osteoarthritis Therapeutics Market Application Outlook (Revenue, USD Million , 2021-2033)
Knee Osteoarthritis
Hip Osteoarthritis
Shoulder Osteoarthritis
Spine Osteoarthritis
Ankle & Foot Osteoarthritis
Other
India Osteoarthritis Therapeutics Market Primary User Outlook (Revenue, USD Million , 2021-2033)
Orthopedic Surgeons
Rheumatologists
Sports Medicine Specialists
Regenerative Medicine Specialists
Other
Reasons to subscribe to Osteoarthritis Therapeutics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Osteoarthritis Therapeutics Market Outlook databook
Our clientele includes a mix of Osteoarthritis Therapeutics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Osteoarthritis Therapeutics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Osteoarthritis Therapeutics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
India Osteoarthritis Therapeutics Market, 2021-2033 (US$M)